Skip to content

Opening book details…

Can I read Polygoni multiflori radix exacerbates idiosyncratic inflammatory liver injury through the FXR-SHP pathway and altered pharmacokinetic behavior on EtoBox?

Polygoni multiflori radix exacerbates idiosyncratic inflammatory liver injury through the FXR-SHP pathway and altered pharmacokinetic behavior by Guoqin Zhang; Jianhua Sun; Meiqi Liu; Zhixiang Tian; Zicheng Ma; Bingyu Hao; Jintang Ning; Xiaoliang Ren; Meng Wang; Ping Wang; Jiunian Li; Hailin Li; Jian Ni; Yi Liu is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Polygoni multiflori radix exacerbates idiosyncratic inflammatory liver injury through the FXR-SHP pathway and altered pharmacokinetic behavior about?

Polygoni multiflori radix (PM) is a well-known tonic herb. It has been reported that PM could cause idiosyncratic inflammatory liver injury in some individuals. In this study, we investigated the mechanism of PM-induced idiosyncratic inflammatory liver injury in zebrafish and rat models based on pharmacodynamics and pharmacokinetics. The zebrafish were administered with polygoni multiflori radix extract (PME), emodin (EMO), and 2,3,5,4′-tetrahydroxystilbene-2-Ο-β-D-glucoside (TSG) after lipopolysaccharide (LPS) treatment, to establish an idiosyncratic inflammation model. In zebrafish with idiosyncratic inflammation, PME, EMO, and TSG decreased liver area and brightness and increased the number of immune cells around the colliculi. PME+LPS produced hepatocyte damage, aggravated mitochondrial and endoplasmic reticulum damage, and increased AST and ALT activity. RT-PCR showed that PME and EMO up-regulated the expression of IL-6, IL-1β, and INF-γ, and PME down-regulated expression of FXR and SHP. In rats with idiosyncratic inflammation, AST and ALT activities increased significantly, and liver tissues showed pathological damage. An efficient and sensitive LC-MS/MS method was establishe

Who reads Polygoni multiflori radix exacerbates idiosyncratic inflammatory liver injury through the FXR-SHP pathway and altered pharmacokinetic behavior?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Guoqin Zhang; Jianhua Sun; Meiqi Liu; Zhixiang Tian; Zicheng Ma; Bingyu Hao; Jintang Ning; Xiaoliang Ren; Meng Wang; Ping Wang; Jiunian Li; Hailin Li; Jian Ni; Yi Liu
Publisher
Elsevier BV
Published
2023
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Guoqin Zhang; Jianhua Sun; Meiqi Liu; Zhixiang Tian; Zicheng Ma; Bingyu Hao; Jintang Ning; Xiaoliang Ren; Meng Wang; Ping Wang; Jiunian Li; Hailin Li; Jian Ni; Yi Liu

Browse all works by Guoqin Zhang; Jianhua Sun; Meiqi Liu; Zhixiang Tian; Zicheng Ma; Bingyu Hao; Jintang Ning; Xiaoliang Ren; Meng Wang; Ping Wang; Jiunian Li; Hailin Li; Jian Ni; Yi Liu